Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Fmoc-Aph(Cbm)-OH;324017-23-4;CID 10694638;(2S)-3-[4-(carbamoylamino)phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid;MFCD30475861;Fmoc-L-Aph(Cbm)-OH;DTXSID001139856;FF72456;CS-0539090;G70842;4-[(Aminocarbonyl)amino]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanine; |
M.F/Formula | C25H23N3O5 |
M.W/Mr. | 445.5 |
Sequence | Three Letter Code:Fmoc-Phe(4-ureido)-OH |
InChI | InChI=1S/C25H23N3O5/c26-24(31)27-16-11-9-15(10-12-16)13-22(23(29)30)28-25(32)33-14-21-19-7-3-1-5-17(19)18-6-2-4-8-20(18)21/h1-12,21-22H,13-14H2,(H,28,32)(H,29,30)(H3,26,27,31)/t22-/m0/s1 |
InChI Key | HFPDOFBZCSQAEJ-QFIPXVFZSA-N |
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.